Nomura Asset Management Co. Ltd. Has $4.62 Million Stock Position in The Cooper Companies, Inc. $COO

Nomura Asset Management Co. Ltd. lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 8.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,852 shares of the medical device company’s stock after purchasing an additional 5,208 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Cooper Companies were worth $4,615,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of COO. Geode Capital Management LLC lifted its position in Cooper Companies by 2.5% in the second quarter. Geode Capital Management LLC now owns 5,205,615 shares of the medical device company’s stock worth $368,893,000 after purchasing an additional 127,907 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Cooper Companies by 3.4% in the 1st quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company’s stock valued at $436,681,000 after buying an additional 172,485 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Cooper Companies by 17.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock worth $399,340,000 after acquiring an additional 686,751 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Cooper Companies by 12.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,954,877 shares of the medical device company’s stock worth $333,595,000 after acquiring an additional 425,400 shares during the period. Finally, Sustainable Growth Advisers LP acquired a new stake in shares of Cooper Companies during the 2nd quarter valued at about $240,881,000. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have commented on COO shares. Weiss Ratings restated a “sell (d+)” rating on shares of Cooper Companies in a research note on Wednesday. Wells Fargo & Company reiterated an “equal weight” rating and issued a $72.00 price objective on shares of Cooper Companies in a research report on Thursday, November 13th. The Goldman Sachs Group set a $64.00 target price on shares of Cooper Companies and gave the stock a “sell” rating in a research report on Wednesday, October 1st. Morgan Stanley set a $76.00 price target on Cooper Companies and gave the company an “equal weight” rating in a report on Thursday, August 28th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $94.00 target price on shares of Cooper Companies in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average price target of $84.77.

Cooper Companies Trading Up 6.1%

Cooper Companies stock opened at $75.47 on Friday. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $106.63. The stock has a market capitalization of $15.00 billion, a P/E ratio of 37.18, a PEG ratio of 1.83 and a beta of 1.02. The stock has a 50-day simple moving average of $70.15 and a 200 day simple moving average of $72.04. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same period in the previous year, the firm earned $0.96 EPS. The firm’s revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its board has authorized a stock buyback program on Wednesday, September 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the medical device company to buy up to 15.4% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

Insider Transactions at Cooper Companies

In related news, Director Lawrence Erik Kurzius bought 2,000 shares of Cooper Companies stock in a transaction that occurred on Monday, September 29th. The stock was acquired at an average price of $68.39 per share, with a total value of $136,780.00. Following the acquisition, the director owned 5,777 shares of the company’s stock, valued at approximately $395,089.03. This represents a 52.95% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Albert G. White III purchased 10,000 shares of the stock in a transaction on Friday, September 5th. The stock was bought at an average cost of $68.39 per share, for a total transaction of $683,900.00. Following the completion of the acquisition, the chief executive officer owned 226,151 shares in the company, valued at approximately $15,466,466.89. This trade represents a 4.63% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders acquired 17,975 shares of company stock valued at $1,216,346. Corporate insiders own 1.98% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.